U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07089784) titled 'Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)' on July 25.
Brief Summary: The purpose of this study is to learn about the safety and if people tolerate a study medicine called MK-2828. The study will also measure what happens to MK-2828 in the body of a person with type 2 diabetes (T2D) over time (pharmacokinetic or PK study), and how it affects the amount of high-sensitivity C-reactive protein (hsCRP) in a person's blood.
Study Start Date: Aug. 26
Study Type: INTERVENTIONAL
Condition:
Diabetes Mellitus, Type 2
Intervention:
DRUG: MK-2828
Oral capsule of MK-2828 taken once per day for 28 da...